Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|March 28, 2009
Meconium aspiration in the midtrimester fetus: an autopsy studyElin Mortensen, Michael Shelley Kearney
The American Journal of Pathology|May 26, 2006
Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cellsManar Kalaaji, Elin Mortensen, Leif Jørgensen, et al.
Virchows Archiv : an International Journal of Pathology|April 10, 2003
Overexpression of IGBFB2 is a marker for malignant transformation in prostate epitheliumElin Richardsen, Tanja Ukkonen, Tone Bjørnsen, et al.
Cancers|December 11, 2025
Digital Pathology with AI for Cervical Biopsies: Diagnostic Accuracy at the CIN2+ ThresholdAnja Kristin Andreassen, Elin Mortensen, Roy Stenbro, et al.
Molecular Medicine (Cambridge, Mass.)|June 12, 2013
Lupus nephritis: enigmas, conflicting models and an emerging conceptNatalya Seredkina, Johan Van Der Vlag, Jo Berden, et al.
Anticancer Research|August 5, 2003
Application of the transgenic adenocarcinoma mouse prostate (TRAMP) model for pre-clinical therapeutic studiesRosetta Martiniello-Wilks, Allison Dane, Elin Mortensen, et al.
Comparative Hepatology|February 12, 2010
Increased sinusoidal flow is not the primary stimulus to liver regenerationKim E Mortensen, Lene N Conley, Ingvild Nygaard, et al.
The Journal of Gene Medicine|October 20, 2004
Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancerRosetta Martiniello-Wilks, Xiao Yang Wang, Dale J Voeks, et al.
The Journal of Gene Medicine|January 13, 2004
Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human diseaseRosetta Martiniello-Wilks, Allison Dane, Dale J Voeks, et al.
Breast Cancer Research and Treatment|July 22, 2025
Higher pre-diagnostic serum syndecan-4 levels are associated with increased breast cancer risk: a case-cohort studyEndre Gabrielsen, Tom Wilsgaard, Hanne Frydenberg, et al.
Pageof 2